childrens-national-7th-symposium-logo

For the third consecutive year, Children’s National Health System is co-locating its annual Symposium with The MedTech Conference, powered by AdvaMed. If you are interested in advancing innovation in pediatrics and exploring solutions to the challenges associated with device trials, we hope that you will join key industry stakeholders at the  7th Annual Pediatric Device Innovation Symposium on Sept. 22 in Boston, one day before The MedTech Conference. 

fund-dollar-money-pixa

Kenton Lee was traveling through Nairobi when he had, as he says jokingly, “the only idea I’ve ever had.” He saw an orphan girl’s shoes that were way too small; someone had cut off the front so her toes could stick through. “Right there, I thought, Wouldn’t it be nice if there were shoes that could grow?” Then he went home to Boise, Idaho, developed a shoe that expands five sizes, and founded the nonprofit Because International -- which today, 12 years later, has distributed more than 250,000 pairs worldwide.

enright-vaccitech-logo.jpg

Vaccitech, a clinical-stage T cell immunotherapy company developing products to treat and prevent cancer and infectious diseases (ID), announced today that it has appointed Bill Enright as its new Chief Executive Officer (CEO). Mr. Enright succeeds Tom Evans, MD who will make a planned transition to the role of Vaccitech’s Chief Scientific Officer.

umd-seal-logo

America's Seed Fund (the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs) annually provides approximately over $3 billion in non-dilutive early-stage technology funding. The SBIR Road Tour is an opportunity for tech innovators, entrepreneurs, and researchers to learn how to access this funding, meet one-on-one with decision makers, and connect with local state innovation ecosystem members. This one-day event will provide attendees, including women and minority entrepreneurs, the opportunity to engage with representatives from various SBIR/STTR agencies.

If you’re an innovator, entrepreneur, researcher, or small technology firm, don’t miss this opportunity!

umd-ibbr-0608-logo

The Institute for Bioscience and Biotechnology Research (IBBR) is interested in proposals to lease a biomanufacturing facility configured to produce biologicals under cGMP conditions in compliance with FDA requirements for phase I/II clinical trials. The facility is also equipped to perform process development research, pre-clinical manufacturing for material necessary to conduct IND-enabling toxicology studies, Proof of Concept (POC) studies, and process demonstration in advance of Good Manufacturing Practices (GMP) manufacturing. IBBR is a joint research enterprise between the University of Maryland and the National Institute of Standards and Technology.

graybug-vision-logo

Graybug Vision, Inc., a clinical stage pharmaceutical company developing potentially transformative long-acting therapies for ocular diseases including wet age-related macular degeneration (wet AMD), diabetic macular edema (DME), retinal vein occlusion (RVO), and primary open angle glaucoma (POAG), today announced the securing of an $80 million Series C financing.

working-to-fight-amr-logo

Leading scientists, public policy experts, and biotech industry leaders joined forces today to launch "Working to Fight AMR," a coalition working to raise public awareness of the growing threat posed by antimicrobial resistance. Working to Fight AMR will also advocate for policies that catalyze the creation of new medicines.

brian-darmody-aurp-image

This article is the second in a 4-part series. Part 1 offered background on innovation districts—what they are, where they’re located, how colleges and universities relate, how P3s relate, etc. Part 3 will look at why schools might want to and might not want to consider pursuing an innovation district. Part 4 will feature an interview with Dr. Jane Talkington, scholar of innovation districts for higher ed. 

What is the difference between research parks and innovation districts?

Darmody: The terms are somewhat interchangeable, but essentially, innovation districts generally are more urban in nature with mixed-use amenities, whereas traditional research parks grew up around universities and are in rural, suburban, and urban areas, such as Boston and Austin, but also Lincoln, Nebraska, and Champaign, Illinois. When it comes down to it, though, they share a base concept: Schools and other anchor institutions are trying to build space-placed entities, and corporations come to the university for things like talent.

newby-va-bio-bendis-image

BHI is looking forward to working and partnering with you. We also want to thank his predecessor, Jeff Gallagher, for his 7 years of service. Thank you for your work to help build the BioHealth Capital Region and its efforts to become the Top 3 by 2023.
 
You can follow along with VirginiaBio at: